Your session is about to expire
← Back to Search
Medical Therapy for Myocardial Bridging
Study Summary
This trial is important because it will help doctors better diagnose and treat a heart condition that affects a lot of people.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Your heart has a lower than normal pumping ability.You had a very bad reaction to beta blockers or calcium channel blockers in the past.Your blood pressure is lower than 100 over 0 or your heart beats slower than 50 times per minute when you are resting.You are 18 years old or older.You have stable chest pain that fits specific criteria.You do not want to take beta blockers or calcium channel blockers.You have recently experienced a serious heart condition like unstable angina, heart attack, or cardiogenic shock.You have had a heart transplant in the past.You have another condition that could explain your chest pain, like lung pressure, heart muscle thickening, or narrowed aortic valve.You don't have any symptoms.You do not have blockages in your heart arteries, as shown by specific tests.You are taking a medication that can have a harmful interaction with beta blockers or calcium channel blockers.You have had an exercise stress test in the past six months.You have had a test that shows you have a condition called myocardial bridge.
- Group 1: Beta Blocker (nebivolol)
- Group 2: Calcium Channel Blocker (diltiazem)
- Group 3: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What further investigations have been conducted regarding the effects of nebivolol?
"Presently, 57 different clinical trials involving nebivolol are ongoing. Of those studies, 19 have progressed to the third phase of development. The majority of these clinical sites are located in Miami; however, globally 6480 locations offer this particular treatment option."
Is the minimum age for eligibility for this trial less than 20 years old?
"To qualify for the trial, applicants must be aged 18-80. Those younger than 18 or older than 65 have 19 and 37 clinical trials available to them respectively."
Who is the ideal candidate for this trial's enrollment?
"In order to qualify for this clinical trial, individuals must have myocardial bridging and be between 18-80 years old. This medical research is attempting to recruit 360 participants in total."
Are there still openings for interested participants in this trial?
"According to clinicaltrials.gov, this medical trial is currently in search of enrollees. This investigation was first posted on October 15th 2020 and last updated on July 2nd 2022."
What is the typical application for Beta Blocker (nebivolol)?
"Nebivolol can be administered to sufferers of kidney failure, proteinuria, and joint ailments."
Has the nebivolol medication been authorized by the FDA?
"The safety of Nebivolol is estimated at a 2 since the Phase 2 trial does not have any data supporting efficacy, but some demonstrating its security."
How many participants are being recruited for this experimental research?
"Affirmative. According to clinicaltrials.gov, this research endeavour is currently searching for 360 participants over the course of 1 medical facility. The trial was initially posted on October 15th 2020 and has been most recently updated on July 2nd 2022."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger